Circulating microparticle signature in coronary and peripheral blood of ST elevation myocardial infarction patients in relation to pain-to-PCI elapsed time

International Journal of Cardiology

Volumn 202, Issue , 2016, Pages 378-387

  Suades, R ^a   Padro T ^a   Crespo, J ^a   Ramaiola, I ^a   Martin Yuste, V ^b   Sabate M ^b   Sans Rosello J ^c   Sionis, A ^c   Badimon, L ^a,d  

^a Institut Català de Ciències Cardiovasculars   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Biomarkers; Circulating cell derived microparticles; Myocardial infarction; Myocardial revascularization; Thrombosis

Indexed keywords

AGED; ARTICLE; BLOOD; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; HEART MUSCLE ISCHEMIA; HUMAN; MEMBRANE MICROPARTICLE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOSIS; CORONARY ARTERY OCCLUSION; CORONARY BLOOD VESSEL; ELECTROCARDIOGRAPHY; FEMALE; FLOW CYTOMETRY; HEART MUSCLE REVASCULARIZATION; MALE; METABOLISM; MIDDLE AGED; MYOCARDIAL INFARCTION; PAIN; PHENOTYPE; PREDICTIVE VALUE; PROCEDURES; SEVERITY OF ILLNESS INDEX; THROMBECTOMY; TRANSLUMINAL CORONARY ANGIOPLASTY;

BIOLOGICAL MARKER;

AGED; ANGIOPLASTY, BALLOON, CORONARY; BIOMARKERS; CELL-DERIVED MICROPARTICLES; CORONARY OCCLUSION; CORONARY VESSELS; ELECTROCARDIOGRAPHY; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PAIN; PERCUTANEOUS CORONARY INTERVENTION; PHENOTYPE; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; THROMBECTOMY; THROMBOSIS;

EID: 84960153162     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.09.011     Document Type: Article

References (46)

1. J. Sanz, P.R. Moreno, and V. Fuster The year in atherothrombosis J. Am. Coll. Cardiol. 62 2013 1131 1143
2. R. Lozano, M. Naghavi, K. Foreman, S. Lim, K. Shibuya, V. Aboyans, and et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2012 2095 2128
3. E. Falk, M. Nakano, J.F. Bentzon, A.V. Finn, and R. Virmani Update on acute coronary syndromes: the pathologists' view Eur. Heart J. 34 2013 719 728
4. V. Fuster, L. Badimon, J.J. Badimon, and J.H. Chesebro The pathogenesis of coronary artery disease and the acute coronary syndromes (2) N. Engl. J. Med. 326 1992 310 318
5. V. Fuster, L. Badimon, J.J. Badimon, and J.H. Chesebro The pathogenesis of coronary artery disease and the acute coronary syndromes (1) N. Engl. J. Med. 326 1992 242 250
6. P.W. Armstrong, A.H. Gershlick, P. Goldstein, R. Wilcox, T. Danays, Y. Lambert, and et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction N. Engl. J. Med. 368 2013 1379 1387
7. G. Cimmino, P. Golino, and J.J. Badimon Pathophysiological role of blood-borne tissue factor: should the old paradigm be revisited? Intern. Emerg. Med. 6 2011 29 34
8. L. Badimon, and G. Vilahur Thrombosis formation on atherosclerotic lesions and plaque rupture J. Intern. Med. 276 2014 618 632
9. I. Ramaiola, T. Padro, E. Pena, O. Juan-Babot, J. Cubedo, V. Martin-Yuste, and et al. Changes in thrombus composition and profilin-1 release in acute myocardial infarction Eur. Heart J. 36 16 2014 965 975 10.1055/s-0035-1556591
10. R. Suades, T. Padro, G. Vilahur, and L. Badimon Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques Thromb. Haemost. 108 2012 1208 1219
11. S.F. Mause Platelet microparticles: reinforcing the hegemony of platelets in atherothrombosis Thromb. Haemost. 109 2013 5 6
12. R. Suades, T. Padró, and L. Badimon The role of blood-borne microparticles in inflammation and hemostasis Semin. Thromb. Hemost. 41 6 2015 590 606 10.1055/s-0035-1556591
13. E. van der Pol, A.N. Boing, P. Harrison, A. Sturk, and R. Nieuwland Classification, functions, and clinical relevance of extracellular vesicles Pharmacol. Rev. 64 2012 676 705
14. P.E. Rautou, A.C. Vion, N. Amabile, G. Chironi, A. Simon, A. Tedgui, and et al. Microparticles, vascular function, and atherothrombosis Circ. Res. 109 2011 593 606
15. Z. Mallat, H. Benamer, B. Hugel, J. Benessiano, P.G. Steg, J.M. Freyssinet, and et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes Circulation 101 2000 841 843
16. O. Morel, B. Hugel, L. Jesel, Z. Mallat, F. Lanza, M.P. Douchet, and et al. Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists J. Thromb. Haemost. 2 2004 1118 1126
17. G. Giannopoulos, G. Oudatzis, G. Paterakis, A. Synetos, E. Tampaki, G. Bouras, and et al. Red blood cell and platelet microparticles in myocardial infarction patients treated with primary angioplasty Int. J. Cardiol. 176 2014 145 150
18. L.M. Biasucci, I. Porto, L. Di Vito, G.L. De Maria, A.M. Leone, G. Tinelli, and et al. Differences in microparticle release in patients with acute coronary syndrome and stable angina Circ. J. 76 2012 2174 2182
19. E. Stepien, E. Stankiewicz, J. Zalewski, J. Godlewski, K. Zmudka, and I. Wybranska Number of microparticles generated during acute myocardial infarction and stable angina correlates with platelet activation Arch. Med. Res. 43 2012 31 35
20. P.M. van der Zee, E. Biro, Y. Ko, R.J. de Winter, C.E. Hack, A. Sturk, and et al. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction Clin. Chem. 52 2006 657 664
21. C. Jung, P. Sorensson, N. Saleh, H. Arheden, L. Ryden, and J. Pernow Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-elevation myocardial infarction Atherosclerosis 221 2012 226 231
22. P.K. Min, J.Y. Kim, K.H. Chung, B.K. Lee, M. Cho, D.L. Lee, and et al. Local increase in microparticles from the aspirate of culprit coronary arteries in patients with ST-segment elevation myocardial infarction Atherosclerosis 227 2013 323 328
23. O. Morel, B. Pereira, G. Averous, A. Faure, L. Jesel, P. Germain, and et al. Increased levels of procoagulant tissue factor-bearing microparticles within the occluded coronary artery of patients with ST-segment elevation myocardial infarction: role of endothelial damage and leukocyte activation Atherosclerosis 204 2009 636 641
24. I. Porto, L.M. Biasucci, G.L. De Maria, A.M. Leone, G. Niccoli, F. Burzotta, and et al. Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention Eur. Heart J. 33 2012 2928 2938
25. + microparticles correlate with cardiovascular outcomes Eur. Heart J. 32 2011 2034 2041
26. + lymphocyte-derived microparticles map lipid-rich atherosclerotic plaques in familial hypercholesterolaemia patients Thromb. Haemost. 111 2014 111 121
27. G. Sarlon-Bartoli, Y. Bennis, R. Lacroix, M.D. Piercecchi-Marti, M.A. Bartoli, L. Arnaud, and et al. Plasmatic level of leukocyte-derived microparticles is associated with unstable plaque in asymptomatic patients with high-grade carotid stenosis J. Am. Coll. Cardiol. 62 2013 1436 1441
28. C.J. Terkelsen, D.S. Pinto, H. Thiele, P. Clemmensen, K. Nikus, J.F. Lassen, and et al. 2012 ESC STEMI guidelines and reperfusion therapy: evidence base ignored, threatening optimal patient management Heart 99 2013 1154 1156
29. R. Suades, T. Padro, R. Alonso, P. Mata, and L. Badimon Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells Thromb. Haemost. 110 2013 366 377
30. + platelet-derived microparticles characterise young patients with high cardiovascular risk and subclinical atherosclerosis Thromb. Haemost. 114 2015 10.1160/TH15-04-0325
31. P. Peduzzi, J. Concato, A.R. Feinstein, and T.R. Holford Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates J. Clin. Epidemiol. 48 1995 1503 1510
32. +-microparticles and decreased levels of activated platelet-derived microparticles. Validation in STEMI patients J. Thromb. Haemost. 2015 10.1111/jth.13065
33. J. Jeanneteau, P. Hibert, M.C. Martinez, S. Tual-Chalot, S. Tamareille, A. Furber, and et al. Microparticle release in remote ischemic conditioning mechanism Am. J. Physiol. 303 2012 H871 H877
34. S. Montoro-Garcia, E. Shantsila, L.D. Tapp, A. Lopez-Cuenca, A.I. Romero, D. Hernandez-Romero, and et al. Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes Atherosclerosis 227 2013 313 322
35. E. Shantsila, L.D. Tapp, B.J. Wrigley, S. Montoro-Garcia, and G.Y. Lip Receptors to interleukin-6 and adhesion molecules on circulating monocyte subsets in acute myocardial infarction Thromb. Haemost. 110 2013 340 348
36. A.S. Leroyer, H. Isobe, G. Leseche, Y. Castier, M. Wassef, Z. Mallat, and et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques J. Am. Coll. Cardiol. 49 2007 772 777
37. C.E. Radecke, A.E. Warrick, G.D. Singh, J. Rogers, S.I. Simon, and E.J. Armstrong Coronary artery endothelial cells and microparticles increase expression of VCAM-1 in myocardial infarction Thromb. Haemost. 113 2014 605 616
38. D. Tousoulis, T. Psaltopoulou, E. Androulakis, N. Papageorgiou, S. Papaioannou, E. Oikonomou, and et al. Oxidative stress and early atherosclerosis: novel antioxidant treatment Cardiovasc. Drugs Ther. 29 2015 75 88
39. + apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease Arterioscler. Thromb. Vasc. Biol. 26 2006 112 116
40. J.P. Empana, C.M. Boulanger, M. Tafflet, J.M. Renard, A.S. Leroyer, O. Varenne, and et al. Microparticles and sudden cardiac death due to coronary occlusion. The TIDE (Thrombus and Inflammation in sudden DEath) study Eur. Heart J. Acute Cardiovasc. Care 4 1 2014 28 36
41. M. Aatonen, M. Gronholm, and P.R. Siljander Platelet-derived microvesicles: multitalented participants in intercellular communication Semin. Thromb. Hemost. 38 2012 102 113
42. J.I. Zwicker, C.C. Trenor 3rd, B.C. Furie, and B. Furie Tissue factor-bearing microparticles and thrombus formation Arterioscler. Thromb. Vasc. Biol. 31 2011 728 733
43. A.S. Leroyer, P.E. Rautou, J.S. Silvestre, Y. Castier, G. Leseche, C. Devue, and et al. CD40 ligand + microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization J. Am. Coll. Cardiol. 52 2008 1302 1311
44. J. Habersberger, F. Strang, A. Scheichl, N. Htun, N. Bassler, R.M. Merivirta, and et al. Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarction Cardiovasc. Res. 96 2012 64 72
45. N.C. Dubois, A.M. Craft, P. Sharma, D.A. Elliott, E.G. Stanley, A.G. Elefanty, and et al. SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells Nat. Biotechnol. 29 2011 1011 1018
46. J.J. Cha, J.Y. Kim, E.Y. Choi, P.K. Min, M. Cho, D.L. Lee, and et al. Effect of abciximab on the levels of circulating microparticles in patients with acute myocardial infarction treated by primary angioplasty Korean Circ. J. 43 2013 600 606